$XXII
22nd Century Group, Inc.

2018 Q4 Form 10-K Financial Statement

#000114420419012540 Filed on March 06, 2019

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2018 Q2
Revenue $7.135M $6.260M $6.915M
YoY Change 20.1% 38.17% 77.43%
Cost Of Revenue $6.620M $6.109M $6.753M
YoY Change 12.79% 25.41% 66.24%
Gross Profit $514.7K $150.9K $161.7K
YoY Change 620.84% -144.35% -197.98%
Gross Profit Margin 7.21% 2.41% 2.34%
Selling, General & Admin $2.237M $1.998M $2.119M
YoY Change -5.99% 4.36% 2.21%
% of Gross Profit 434.67% 1323.6% 1310.09%
Research & Development $3.682M $4.010M $4.781M
YoY Change 201.78% 411.07% 487.91%
% of Gross Profit 715.26% 2656.4% 2956.71%
Depreciation & Amortization $396.0K $132.8K $131.3K
YoY Change 52.31% 49.75% 48.42%
% of Gross Profit 76.93% 88.01% 81.19%
Operating Expenses $6.315M $6.360M $7.202M
YoY Change 64.46% 116.78% 131.03%
Operating Profit -$5.801M -$6.209M -$7.041M
YoY Change 53.72% 89.64% 114.48%
Interest Expense -$3.119M $4.431K $0.00
YoY Change -7897.23% -36.55% -100.0%
% of Operating Profit
Other Income/Expense, Net -$9.790M $12.51M $301.9K
YoY Change -29506.83% -512.95%
Pretax Income -$8.919M $6.305M -$6.739M
YoY Change 138.49% -290.09% 100.82%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$8.919M $6.305M -$6.739M
YoY Change 138.77% -290.09% 100.82%
Net Earnings / Revenue -125.01% 100.71% -97.45%
Basic Earnings Per Share $0.05
Diluted Earnings Per Share -$0.07 $0.04 -$0.05
COMMON SHARES
Basic Shares Outstanding 124.4M shares 124.4M shares 124.3M shares
Diluted Shares Outstanding 144.4M shares

Balance Sheet

Concept 2018 Q4 2018 Q3 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $56.35M $62.12M $53.45M
YoY Change -10.04% 313.59% 328.29%
Cash & Equivalents $604.9K $759.2K $3.373M
Short-Term Investments $55.75M $61.36M $50.08M
Other Short-Term Assets $928.4K $1.280M $1.320M
YoY Change 23.79% 137.05% 140.0%
Inventory $3.044M $3.330M $2.943M
Prepaid Expenses
Receivables $871.3K $936.2K $1.283M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $61.20M $67.67M $59.00M
YoY Change -9.5% 242.97% 227.06%
LONG-TERM ASSETS
Property, Plant & Equipment $3.261M $3.307M $3.417M
YoY Change -1.67% 6.66% 50.42%
Goodwill
YoY Change
Intangibles $9.752M $8.710M $8.640M
YoY Change 31.15% 16.07%
Long-Term Investments $3.092M $6.731M $7.510M
YoY Change 125.72% 391.32% 449.58%
Other Assets
YoY Change
Total Long-Term Assets $16.10M $18.75M $19.57M
YoY Change 32.9% 57.15% 76.61%
TOTAL ASSETS
Total Short-Term Assets $61.20M $67.67M $59.00M
Total Long-Term Assets $16.10M $18.75M $19.57M
Total Assets $77.30M $86.42M $78.57M
YoY Change -3.06% 172.95% 169.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.575M $3.853M $3.050M
YoY Change 23.75% 136.39% 34.43%
Accrued Expenses $1.826M $1.902M $1.921M
YoY Change -8.11% 40.91% 28.05%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $689.2K $392.7K $390.0K
YoY Change 19.0% 21.88%
Total Short-Term Liabilities $5.174M $6.634M $5.778M
YoY Change 19.95% 91.74% 41.39%
LONG-TERM LIABILITIES
Long-Term Debt $848.2K $287.0K $290.0K
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0%
Total Long-Term Liabilities $848.2K $287.0K $290.0K
YoY Change 43.49% 107.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.174M $6.634M $5.778M
Total Long-Term Liabilities $848.2K $287.0K $290.0K
Total Liabilities $6.022M $6.921M $6.064M
YoY Change 39.61% 89.1% 43.4%
SHAREHOLDERS EQUITY
Retained Earnings -$99.13M -$90.22M -$96.52M
YoY Change 8.74% 14.75%
Common Stock $1.246K $1.244K $1.243K
YoY Change 0.81% 28.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $71.28M $79.49M $72.51M
YoY Change
Total Liabilities & Shareholders Equity $77.30M $86.42M $78.57M
YoY Change -3.06% 172.95% 169.81%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2018 Q2
OPERATING ACTIVITIES
Net Income -$8.919M $6.305M -$6.739M
YoY Change 138.77% -290.09% 100.82%
Depreciation, Depletion And Amortization $396.0K $132.8K $131.3K
YoY Change 52.31% 49.75% 48.42%
Cash From Operating Activities -$5.283M -$4.172M -$5.250M
YoY Change 115.62% 62.32% 20.69%
INVESTING ACTIVITIES
Capital Expenditures -$338.2K -$178.8K -$110.0K
YoY Change 141.59% -0.68% 10.0%
Acquisitions
YoY Change
Other Investing Activities $5.539M $1.743M $3.680M
YoY Change -109.35% -298.02%
Cash From Investing Activities $5.201M $1.554M $3.580M
YoY Change -108.76% -247.98% -3354.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -72.89K -2.500K -500.0K
YoY Change -100.14% -100.04% -108.05%
NET CHANGE
Cash From Operating Activities -5.283M -4.172M -5.250M
Cash From Investing Activities 5.201M 1.554M 3.580M
Cash From Financing Activities -72.89K -2.500K -500.0K
Net Change In Cash -154.3K -2.620M -2.170M
YoY Change -98.64% -202.76% -224.0%
FREE CASH FLOW
Cash From Operating Activities -$5.283M -$4.172M -$5.250M
Capital Expenditures -$338.2K -$178.8K -$110.0K
Free Cash Flow -$4.944M -$3.993M -$5.140M
YoY Change 114.04% 67.06% 20.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
604925
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3659534
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
55748939
CY2017Q4 us-gaap Short Term Investments
ShortTermInvestments
58975513
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
871293
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
957066
CY2018Q4 us-gaap Inventory Net
InventoryNet
3043949
CY2017Q4 us-gaap Inventory Net
InventoryNet
3282537
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
928420
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
746805
CY2018Q4 us-gaap Assets Current
AssetsCurrent
61197526
CY2017Q4 us-gaap Assets Current
AssetsCurrent
67621455
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3260748
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3316047
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9751504
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7435411
CY2018Q4 us-gaap Long Term Investments
LongTermInvestments
3092358
CY2017Q4 us-gaap Long Term Investments
LongTermInvestments
1366493
CY2018Q4 xxii Assests Noncurrent Excluding Property Plant And Equipment Net
AssestsNoncurrentExcludingPropertyPlantAndEquipmentNet
12843862
CY2017Q4 xxii Assests Noncurrent Excluding Property Plant And Equipment Net
AssestsNoncurrentExcludingPropertyPlantAndEquipmentNet
8801904
CY2018Q4 us-gaap Assets
Assets
77302136
CY2017Q4 us-gaap Assets
Assets
79739406
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2574840
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2080691
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1826481
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1987675
CY2018Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
83075
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
28350
CY2018Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0
CY2017Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
216490
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5173544
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4313206
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
1246
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
1236
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
170392249
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
166592536
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-99134483
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-91167572
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
71280375
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
75426200
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
77302136
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
79739406
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2018Q4 xxii Inventory Tobacco Leaf Gross
InventoryTobaccoLeafGross
1556581
CY2017Q4 xxii Inventory Tobacco Leaf Gross
InventoryTobaccoLeafGross
1552474
CY2018Q4 us-gaap Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
156702
CY2017Q4 us-gaap Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
289004
CY2018Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1430666
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
819640
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
593562
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
516056
CY2018 us-gaap Advertising Expense
AdvertisingExpense
36000
CY2017 us-gaap Advertising Expense
AdvertisingExpense
75000
CY2016 us-gaap Advertising Expense
AdvertisingExpense
325000
CY2017Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1636059
CY2018Q4 xxii Inventorytobacco Leaf Net
InventorytobaccoLeafNet
3143949
CY2017Q4 xxii Inventorytobacco Leaf Net
InventorytobaccoLeafNet
3477537
CY2018Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
100000
CY2017Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
195000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5018247
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4551420
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1757499
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1235373
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-21653
CY2018 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
14492968
CY2017 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0
CY2018 xxii Inventory Reserve Adjustments
InventoryReserveAdjustments
95000
CY2018 us-gaap Depreciation
Depreciation
522695
CY2017 us-gaap Depreciation
Depreciation
353435
CY2016 us-gaap Depreciation
Depreciation
326124
CY2018 us-gaap Revenues
Revenues
26426347
CY2017 us-gaap Revenues
Revenues
16600244
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
25527360
CY2017 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17308156
CY2018 us-gaap Gross Profit
GrossProfit
898987
CY2017 us-gaap Gross Profit
GrossProfit
-707912
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14989746
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3366468
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7658119
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7116535
CY2018 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
927414
CY2017 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1161952
CY2018 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
819640
CY2017 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
593562
CY2018 us-gaap Operating Expenses
OperatingExpenses
24917614
CY2017 us-gaap Operating Expenses
OperatingExpenses
12591952
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-24018627
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-13299864
CY2018 xxii Gain Loss From Warrant Liability
GainLossFromWarrantLiability
48711
CY2017 xxii Gain Loss From Warrant Liability
GainLossFromWarrantLiability
-157809
CY2018 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-54451
CY2018 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
1069036
CY2017 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
115098
CY2018 us-gaap Interest Expense
InterestExpense
10939
CY2017 us-gaap Interest Expense
InterestExpense
29104
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
16051716
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
270747
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7966911
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13029117
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016 us-gaap Revenues
Revenues
12279979
CY2016 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12709678
CY2016 us-gaap Gross Profit
GrossProfit
-429699
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2340958
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6193269
CY2016 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1581741
CY2016 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
516056
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-11387847
CY2016 xxii Gain Loss From Warrant Liability
GainLossFromWarrantLiability
29615
CY2016 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
16885
CY2016 us-gaap Interest Expense
InterestExpense
37745
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-193583
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11581430
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016 us-gaap Operating Expenses
OperatingExpenses
10958148
CY2016Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
13781921
CY2018 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
48711
CY2016 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
29615
CY2016Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
58681
CY2017 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
157809
CY2017 us-gaap Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment
ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
0
CY2017Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
216490
CY2018 us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
48711
CY2018Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
0
CY2017 xxii Number Of Warrants Exercised On Cashless Basis
NumberOfWarrantsExercisedOnCashlessBasis
1286277
CY2017 xxii Warrants Expired And Unexercised
WarrantsExpiredAndUnexercised
223814
CY2018Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.15
CY2018 xxii Number Of Noncash Warrants Exercised
NumberOfNoncashWarrantsExercised
794869
CY2018 xxii Stock Issued During Period Value Warrants Exercise
StockIssuedDuringPeriodValueWarrantsExercise
0
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
444613
CY2018 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3187331
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-7966911
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
11728500
CY2016 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
894715
CY2016 xxii Stock Issued During Period Value Warrants Exercise
StockIssuedDuringPeriodValueWarrantsExercise
196
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
24334359
CY2017 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
941650
CY2017 xxii Stock Issued During Period Value Warrants Exercise
StockIssuedDuringPeriodValueWarrantsExercise
12447108
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1199794
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
848974
CY2018 xxii Amortization Of License Fees
AmortizationOfLicenseFees
142541
CY2017 xxii Amortization Of License Fees
AmortizationOfLicenseFees
98022
CY2018 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
284400
CY2017 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
342562
CY2018 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-54451
CY2017 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0
CY2018 xxii Gain Loss From Warrant Liability
GainLossFromWarrantLiability
48711
CY2017 xxii Gain Loss From Warrant Liability
GainLossFromWarrantLiability
-157809
CY2018 us-gaap Accretion Expense
AccretionExpense
10939
CY2017 us-gaap Accretion Expense
AccretionExpense
29104
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
3187331
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
941650
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0
CY2017 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-10000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-85773
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
906074
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-333588
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
129228
CY2018 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
181615
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
744157
CY2016 xxii Amortization Of License Fees
AmortizationOfLicenseFees
98022
CY2016 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-202338
CY2016 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0
CY2016 xxii Gain Loss From Warrant Liability
GainLossFromWarrantLiability
29615
CY2016 us-gaap Accretion Expense
AccretionExpense
37745
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
880509
CY2016 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10238
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
531356
CY2017 xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
-1470027
CY2017 xxii Number Of Warrants Expired
NumberOfWarrantsExpired
223814
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
12088080
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11293211
CY2018Q4 us-gaap Royalty Guarantees Commitments Amount
RoyaltyGuaranteesCommitmentsAmount
225000
CY2017 xxii Inventory Reserve Adjustments
InventoryReserveAdjustments
60623
CY2017 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
551236
CY2018 xxii Milestone Payment
MilestonePayment
150000
CY2018Q4 xxii Minimum Annual Royalties In Year One
MinimumAnnualRoyaltiesInYearOne
10000
CY2018Q4 xxii Minimum Annua Lroyalties In Year Two
MinimumAnnuaLroyaltiesInYearTwo
15000
CY2018 xxii Capitalized Patent Costs Gross
CapitalizedPatentCostsGross
25000
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
162408
CY2014Q3 xxii License Maintenance Fees Due Current
LicenseMaintenanceFeesDueCurrent
75000
CY2018Q4 xxii Minimum Annual Royalties In Year Three
MinimumAnnualRoyaltiesInYearThree
25000
CY2018 xxii Lease Payments
LeasePayments
169000
CY2017 xxii Lease Payments
LeasePayments
156000
CY2016 xxii Lease Payments
LeasePayments
146000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
169000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
169000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
141000
CY2016Q2 us-gaap Royalty Guarantees Commitments Amount
RoyaltyGuaranteesCommitmentsAmount
1471
CY2017Q1 us-gaap Royalty Guarantees Commitments Amount
RoyaltyGuaranteesCommitmentsAmount
1219
CY2018Q1 xxii Operating Leases Monthly Lease Payment
OperatingLeasesMonthlyLeasePayment
5706
CY2016Q2 xxii Litigation Settlement Shares To Be Issued
LitigationSettlementSharesToBeIssued
2077555
CY2016Q2 xxii Litigation Settlement Shares To Be Issued
LitigationSettlementSharesToBeIssued
2077555
CY2017Q4 xxii Litigation Settlement Shares To Be Issued
LitigationSettlementSharesToBeIssued
2077555
CY2018Q4 us-gaap Loss Contingency Receivable
LossContingencyReceivable
18000000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.81
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.28
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2628622
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
750265
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-7966911
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-13029117
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
124298981
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101161380
CY2018 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2017 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
124298981
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
101161380
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-11581430
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79842773
CY2016 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79842773
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19965293
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20244771
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19432600
CY2018Q4 us-gaap Notes Payable Current
NotesPayableCurrent
689148
CY2017Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0
CY2018Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
848217
CY2017Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
0
CY2018Q4 us-gaap Liabilities
Liabilities
6021761
CY2017Q4 us-gaap Liabilities
Liabilities
4313206
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
21363
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0
CY2018 xxii Realized Gain Loss On Investments
RealizedGainLossOnInvestments
14492968
CY2017 xxii Realized Gain Loss On Investments
RealizedGainLossOnInvestments
0
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-21653
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7945548
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13029117
CY2016 xxii Realized Gain Loss On Investments
RealizedGainLossOnInvestments
0
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11581430
CY2018 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
656985
CY2017 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
450208
CY2018 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
448639
CY2017 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
1156906
CY2018 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
13051503
CY2018 us-gaap Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment
ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
37415159
CY2018 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
34215994
CY2017 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
58979131
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
15145044
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-60586245
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3054609
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-9808654
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13468188
CY2018 us-gaap Interest Paid Net
InterestPaidNet
0
CY2017 us-gaap Interest Paid Net
InterestPaidNet
29104
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2018 xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
152322
CY2017 xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
188818
CY2018 xxii Machinery And Equipment Additions Included In Accounts Payable
MachineryAndEquipmentAdditionsIncludedInAccountsPayable
18757
CY2017 xxii Machinery And Equipment Additions Included In Accounts Payable
MachineryAndEquipmentAdditionsIncludedInAccountsPayable
77913
CY2018 xxii License Acquired With Note Payable
LicenseAcquiredWithNotePayable
2326427
CY2017 xxii License Acquired With Note Payable
LicenseAcquiredWithNotePayable
0
CY2018 xxii Reclassification Of Warrants Liability To Capital In Excess Of Par Value
ReclassificationOfWarrantsLiabilityToCapitalInExcessOfParValue
167779
CY2017 xxii Reclassification Of Warrants Liability To Capital In Excess Of Par Value
ReclassificationOfWarrantsLiabilityToCapitalInExcessOfParValue
0
CY2016 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0
CY2016 xxii Inventory Reserve Adjustments
InventoryReserveAdjustments
-145000
CY2016 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-497856
CY2016 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
356541
CY2016 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
197229
CY2016 us-gaap Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment
ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
0
CY2016 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-553770
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
9707891
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3760297
CY2016 us-gaap Interest Paid Net
InterestPaidNet
37745
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2016 xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
185341
CY2016 xxii Machinery And Equipment Additions Included In Accounts Payable
MachineryAndEquipmentAdditionsIncludedInAccountsPayable
7765
CY2016 xxii License Acquired With Note Payable
LicenseAcquiredWithNotePayable
0
CY2016 xxii Reclassification Of Warrants Liability To Capital In Excess Of Par Value
ReclassificationOfWarrantsLiabilityToCapitalInExcessOfParValue
2810000
CY2018Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
0
CY2017Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
3000000
CY2018Q3 xxii Fair Value Of Common Stock Transferred
FairValueOfCommonStockTransferred
9221594
CY2018Q3 xxii Fair Value Of Warrants
FairValueOfWarrants
2807958
CY2018 xxii Realized Gain On Sale Of Common Stock
RealizedGainOnSaleOfCommonStock
3829909
CY2018Q2 xxii Aggregate Milestone Payments To Be Made
AggregateMilestonePaymentsToBeMade
1200000
CY2018Q2 xxii Milestone Payable Upon Execution Of Second Amendment
MilestonePayableUponExecutionOfSecondAmendment
500000
CY2018Q2 xxii Milestone Payable On First Anniversary Of Execution Of Second Amendment
MilestonePayableOnFirstAnniversaryOfExecutionOfSecondAmendment
400000
CY2018Q2 xxii Milestone Payable On Second Anniversary Of Execution Of Second Amendment
MilestonePayableOnSecondAnniversaryOfExecutionOfSecondAmendment
300000
CY2018Q2 us-gaap Notes Payable
NotesPayable
1175226
CY2018Q4 us-gaap Notes Payable
NotesPayable
684117
CY2018 xxii Reclassification Of Warrant Liability To Capital
ReclassificationOfWarrantLiabilityToCapital
-167779
CY2017 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
12249327
CY2018 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
490012
CY2017Q1 xxii License Expenses
LicenseExpenses
85681
CY2018Q4 xxii Aggregate Milestone Payments To Be Made
AggregateMilestonePaymentsToBeMade
1200000
CY2018Q2 xxii License Acquired With Note Payable
LicenseAcquiredWithNotePayable
1175226
CY2018Q2 us-gaap Other Commitment
OtherCommitment
75000
CY2018 xxii License Expenses
LicenseExpenses
9800000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0277
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0205
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0131
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
900000
CY2018 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
284400
CY2017 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
342562
CY2016 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-202338
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
124642593
CY2018 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0
CY2017 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0
CY2016 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
30873
CY2017 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0
CY2016 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0
CY2018 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
800000
CY2017 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
333334
CY2016 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
333333
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
444613
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2018 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
CY2017 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
12447108
CY2016 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
196
CY2018 xxii Proceeds From Issuance Registered Direct Offering One
ProceedsFromIssuanceRegisteredDirectOfferingOne
0
CY2017 xxii Proceeds From Issuance Registered Direct Offering One
ProceedsFromIssuanceRegisteredDirectOfferingOne
50732200
CY2016 xxii Proceeds From Issuance Registered Direct Offering One
ProceedsFromIssuanceRegisteredDirectOfferingOne
0
CY2018 xxii Proceeds From Issuance Registered Direct Offering Two
ProceedsFromIssuanceRegisteredDirectOfferingTwo
0
CY2017 xxii Proceeds From Issuance Registered Direct Offering Two
ProceedsFromIssuanceRegisteredDirectOfferingTwo
0
CY2016 xxii Proceeds From Issuance Registered Direct Offering Two
ProceedsFromIssuanceRegisteredDirectOfferingTwo
10707823
CY2018 xxii Proceeds From Issuance Registered Direct Offering Three
ProceedsFromIssuanceRegisteredDirectOfferingThree
0
CY2017 xxii Proceeds From Issuance Registered Direct Offering Three
ProceedsFromIssuanceRegisteredDirectOfferingThree
0
CY2016 xxii Proceeds From Issuance Registered Direct Offering Three
ProceedsFromIssuanceRegisteredDirectOfferingThree
4682764
CY2018 xxii Proceeds From Issuance Registered Direct Offering Four
ProceedsFromIssuanceRegisteredDirectOfferingFour
0
CY2017 xxii Proceeds From Issuance Registered Direct Offering Four
ProceedsFromIssuanceRegisteredDirectOfferingFour
0
CY2016 xxii Proceeds From Issuance Registered Direct Offering Four
ProceedsFromIssuanceRegisteredDirectOfferingFour
5091791
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-355387
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
62845974
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20149241
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
323070
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
473804
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-136297
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-166873
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
586109
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-21965
CY2018 xxii Increase Decrease In Accrued Severance
IncreaseDecreaseInAccruedSeverance
0
CY2017 xxii Increase Decrease In Accrued Severance
IncreaseDecreaseInAccruedSeverance
-203365
CY2016 xxii Increase Decrease In Accrued Severance
IncreaseDecreaseInAccruedSeverance
-233655
CY2018 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
54725
CY2017 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
28350
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17844266
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12068383
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9887580
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates </div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">- </div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016 xxii Common Stock Issued During Period Value Registered Direct Offering One
CommonStockIssuedDuringPeriodValueRegisteredDirectOfferingOne
5091791
CY2016 xxii Common Stock Issued During Period Value Registered Direct Offering Two
CommonStockIssuedDuringPeriodValueRegisteredDirectOfferingTwo
4682764
CY2016 xxii Common Stock Issued During Period Value Registered Direct Offering Three
CommonStockIssuedDuringPeriodValueRegisteredDirectOfferingThree
10707823
CY2016 xxii Reclassification Of Warrant Liability To Capital In Excess Of Par
ReclassificationOfWarrantLiabilityToCapitalInExcessOfPar
2810000
CY2016 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
0
CY2017 xxii Common Stock Issues During Period Value Private Placement
CommonStockIssuesDuringPeriodValuePrivatePlacement
50732200
CY2018 xxii Reclassification Of Warrant Liability To Capital In Excess Of Par
ReclassificationOfWarrantLiabilityToCapitalInExcessOfPar
167779
CY2018 us-gaap Dividend Income Operating
DividendIncomeOperating
221991
CY2017 us-gaap Dividend Income Operating
DividendIncomeOperating
0
CY2016 us-gaap Dividend Income Operating
DividendIncomeOperating
0
CY2018 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
141083
CY2017 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
98368
CY2016 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
84499
CY2018Q1 us-gaap Revenues
Revenues
6116309
CY2018Q2 us-gaap Revenues
Revenues
6914913
CY2018Q3 us-gaap Revenues
Revenues
6260158
CY2018Q4 us-gaap Revenues
Revenues
7134967
CY2018Q1 us-gaap Gross Profit
GrossProfit
71578
CY2018Q2 us-gaap Gross Profit
GrossProfit
161714
CY2018Q3 us-gaap Gross Profit
GrossProfit
150949
CY2018Q4 us-gaap Gross Profit
GrossProfit
514746
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4968772
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7040512
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6208834
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-5800509
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
1386488
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-6738652
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
6304654
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-8919401
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.01
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.05
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2017Q1 us-gaap Revenues
Revenues
2231517
CY2017Q2 us-gaap Revenues
Revenues
3897206
CY2017Q3 us-gaap Revenues
Revenues
4530865
CY2017Q4 us-gaap Revenues
Revenues
5940656
CY2017Q1 us-gaap Gross Profit
GrossProfit
-273897
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2969949
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3282525
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3274081
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-3773309
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-2621277
CY2017Q2 us-gaap Gross Profit
GrossProfit
-165055
CY2017Q3 us-gaap Gross Profit
GrossProfit
-340369
CY2017Q4 us-gaap Gross Profit
GrossProfit
71409
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-3355624
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-3316634
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-3735582
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2017Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Method
FiniteLivedIntangibleAssetsAmortizationMethod
will be amortized on a straight-line basis over the last-to-expire patent, which is expected to be in 2036.
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1263677
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-2424497
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
214628
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
21452
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1478305
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2403045
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1478305
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2403045
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y7M10D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M22D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y10M13D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M18D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y4M24D
CY2018 xxii Deferred Tax Assets Increase Decrease Percent
DeferredTaxAssetsIncreaseDecreasePercent
0.46
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements Other
EffectiveIncomeTaxRateReconciliationTaxSettlementsOther
-0.024
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements Other
EffectiveIncomeTaxRateReconciliationTaxSettlementsOther
-0.002
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.004
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.119
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.020
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.015
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.018
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.001
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.001
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.461
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.114
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.207
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
9917641
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
11626143
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
0
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
3499
CY2017Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
48011
CY2016Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
96934
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
388925
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
282850
CY2017Q4 xxii Deferred Tax Liabilities Start Up Expenditures
DeferredTaxLiabilitiesStartUpExpenditures
279709
CY2016Q4 xxii Deferred Tax Liabilities Start Up Expenditures
DeferredTaxLiabilitiesStartUpExpenditures
477917
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
232198
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
0
CY2017Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
11760
CY2016Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
139676
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Severance Payments
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments
0
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Severance Payments
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments
69860
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
4272
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
21423
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
10882516
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
12718302
CY2017Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
220888
CY2016Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
316232
CY2017Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
558760
CY2016Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
807137
CY2017Q4 xxii Deferred Tax Liabilities Other Intangible Assets
DeferredTaxLiabilitiesOtherIntangibleAssets
124953
CY2016Q4 xxii Deferred Tax Liabilities Other Intangible Assets
DeferredTaxLiabilitiesOtherIntangibleAssets
138713
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
904601
CY2016Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1262082
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9977915
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11456220
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
123569367
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
124642593
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
123569367
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2018Q4 xxii Milestone Payable Upon Execution Of Second Amendment
MilestonePayableUponExecutionOfSecondAmendment
300000
CY2018Q4 xxii Milestone Payable On First Anniversary Of Execution Of Second Amendment
MilestonePayableOnFirstAnniversaryOfExecutionOfSecondAmendment
300000
CY2018Q4 us-gaap Notes Payable
NotesPayable
1151201
CY2018Q4 xxii Milestone Payable On Second Anniversary Of Execution Of Second Amendment
MilestonePayableOnSecondAnniversaryOfExecutionOfSecondAmendment
300000
CY2018Q4 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
1151201
CY2017 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-157809
CY2018Q4 us-gaap Defined Benefit Plan Funded Percentage
DefinedBenefitPlanFundedPercentage
0.03
CY2018Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
6147088
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2018Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
300000
CY2018 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
27042
CY2017 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
0
CY2016 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
0
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1446323
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-13927
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1460250
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1460250
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements Other
EffectiveIncomeTaxRateReconciliationTaxSettlementsOther
0.001
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.025
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.012
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.001
CY2018 us-gaap Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
0.015
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.183
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
11526599
CY2018Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
21000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
813585
CY2018Q4 xxii Deferred Tax Liabilities Start Up Expenditures
DeferredTaxLiabilitiesStartUpExpenditures
242704
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
326269
CY2018Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
760
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
19605
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
13051418
CY2018Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
214587
CY2018Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
562140
CY2018Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
612286
CY2018Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
70933
CY2018Q4 xxii Deferred Tax Liabilities Other Intangible Assets
DeferredTaxLiabilitiesOtherIntangibleAssets
153307
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1613253
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11438165
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
0
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Severance Payments
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments
0
CY2017Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
0
CY2016Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
0
CY2017Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
0
CY2016Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
0
CY2018 xxii June Two Thousand Seventeen Warrant Exercise Agreements Disclosure
JuneTwoThousandSeventeenWarrantExerciseAgreementsDisclosure
<div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 3. &#8211; JUNE 2017 WARRANT EXERCISE AGREEMENTS</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: 0.5in; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On June 19, 2017, the Company entered into Warrant Exercise Agreements (the &#8220;Agreements&#8221;) with all the holders (the &#8220;Holders&#8221;) of outstanding warrants to purchase up to 7,043,211 shares of common stock of the Company at $1.00 per share and warrants to purchase up to 4,250,000 shares of common stock of the Company at $1.45 per share (collectively, the &#8220;Warrants&#8221;). These Warrants to purchase shares of the Company&#8217;s common stock were acquired by the Holders in registered direct offerings in October of 2016 and in July of 2016, respectively. The Company and the Holders agreed that the Holders would, subject to beneficial ownership limitations on exercise contained in the Warrants, exercise all the Warrants for cash. During the second and third quarters of 2017, the Holders exercised 7,043,211 Warrants at $1.00 per share and 4,250,000 Warrants at $1.45 per share, resulting in net proceeds to the Company in the amount of $12,336,858, after deducting expenses associated with the transaction.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: 0.5in; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In consideration for the Holders exercising their Warrants for cash, the Company issued to each Holder a new warrant (the &#8220;New Warrants&#8221;) to purchase shares of common stock of the Company equal to the number of shares of common stock received by each Holder upon the cash exercise of the Holder&#8217;s Warrants. The terms of the New Warrants are substantially similar to the terms of the Warrants exercised, except the New Warrants (i) have an exercise price equal to $2.15 per share and (ii) are exercisable six months from the date of issuance of the New Warrants for a period of five (5) years. Accordingly, the Company issued an aggregate of 11,293,211 New Warrants to the Holders, upon exercise of the Holder&#8217;s Warrants as described above. The New Warrants had a fair value of $16,049,031 at issuance and have been recorded as an adjustment to capital in excess of par value.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017 us-gaap Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
0
CY2016 us-gaap Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
0
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2018Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
1.00
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0
CY2017 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
0
CY2016 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
0
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
43050306
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
43082677
CY2018Q4 xxii Available For Sale Securities Debt Maturities After One Year Through Two Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneYearThroughTwoYearsAmortizedCost
2587619
CY2018Q4 xxii Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
2582290
CY2018Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
45664967
CY2018 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-43016
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
45637925
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
76324
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
49282
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
45664967
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
21363
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="color: rgb(0, 0, 0); font-family: &quot;times new roman&quot;, times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-weight: normal; display: inline;"><div style="font-style: normal; display: inline;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Concentration of Credit Risk&#160;-&#160;</div></div></div></div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; letter-spacing: 0px; top: 0px;;display:inline;">The Company maintains its cash in bank deposits which, at times, may exceed federally insured limits. The Company has not experienced any losses on such accounts. The Company believes it is not exposed to any significant risk with respect to its cash accounts.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-weight: normal; display: inline;"><div style="font-style: normal; display: inline;">&#160;</div><div style="font-style: normal; display: inline;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; letter-spacing: 0px; top: 0px;;display:inline;">Reclassifications&#160;-</div>&#160;</div></div></div></div></div></div> <div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; letter-spacing: 0px; top: 0px;;display:inline;">Certain items in the 2017 and 2016 financial statements have been reclassified to conform to the 2018 classification.</div></div><div style="color: rgb(0, 0, 0); font-family: &quot;times new roman&quot;, times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-weight: normal; display: inline;"><div style="font-style: normal; display: inline;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018 dei Document Type
DocumentType
10-K
CY2018 dei Amendment Flag
AmendmentFlag
false
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-12-31
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018 dei Entity Registrant Name
EntityRegistrantName
22nd Century Group, Inc.
CY2018 dei Entity Central Index Key
EntityCentralIndexKey
0001347858
CY2018 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2018 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2018 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2018 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2018Q2 dei Entity Public Float
EntityPublicFloat
292000000
CY2018 dei Trading Symbol
TradingSymbol
XXII
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
124642593
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018 dei Entity Small Business
EntitySmallBusiness
false
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
7700000
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
46900000
CY2018Q4 xxii Deferred Tax Assets Accrued Bonus
DeferredTaxAssetsAccruedBonus
100896
CY2017Q4 xxii Deferred Tax Assets Accrued Bonus
DeferredTaxAssetsAccruedBonus
0
CY2016Q4 xxii Deferred Tax Assets Accrued Bonus
DeferredTaxAssetsAccruedBonus
0

Files In Submission

Name View Source Status
0001144204-19-012540-index-headers.html Edgar Link pending
0001144204-19-012540-index.html Edgar Link pending
0001144204-19-012540.txt Edgar Link pending
0001144204-19-012540-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv512599_10k.htm Edgar Link pending
tv512599_ex10-15.htm Edgar Link pending
tv512599_ex10-16.htm Edgar Link pending
tv512599_ex23-1.htm Edgar Link pending
tv512599_ex31-1.htm Edgar Link pending
tv512599_ex31-2.htm Edgar Link pending
tv512599_ex32-1.htm Edgar Link pending
tv512599_img1.jpg Edgar Link pending
xxii-20181231.xml Edgar Link completed
xxii-20181231.xsd Edgar Link pending
xxii-20181231_cal.xml Edgar Link unprocessable
xxii-20181231_def.xml Edgar Link unprocessable
xxii-20181231_lab.xml Edgar Link unprocessable
xxii-20181231_pre.xml Edgar Link unprocessable